PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,370,150 | -34.9% | 207,632 | -15.0% | 0.02% | -36.0% |
| Q2 2023 | $9,787,979 | +35.9% | 244,272 | +38.5% | 0.02% | +31.6% |
| Q1 2023 | $7,199,905 | +124.6% | 176,425 | +112.5% | 0.02% | +111.1% |
| Q4 2022 | $3,205,132 | -23.3% | 83,013 | +5.7% | 0.01% | -30.8% |
| Q3 2022 | $4,177,000 | +2.6% | 78,531 | +12.5% | 0.01% | +18.2% |
| Q2 2022 | $4,071,000 | +11.8% | 69,825 | +46.3% | 0.01% | +22.2% |
| Q1 2022 | $3,642,000 | +143.8% | 47,721 | +92.2% | 0.01% | +125.0% |
| Q4 2021 | $1,494,000 | – | 24,832 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |